Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Genetics

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 14 articles:
HTML format



Single Articles


    November 2022
  1. SAFDAR NS, Stasenko M, Selenica P, Martin AS, et al
    Genomic Determinants of Early Recurrences in Low-Stage, Low-Grade Endometrioid Endometrial Carcinoma.
    J Natl Cancer Inst. 2022;114:1545-1548.
    PubMed     Abstract available


    September 2022
  2. UMEMOTO K, Yamamoto H, Oikawa R, Takeda H, et al
    The Molecular Landscape of Pancreatobiliary Cancers for Novel Targeted Therapies From Real-World Genomic Profiling.
    J Natl Cancer Inst. 2022;114:1279-1286.
    PubMed     Abstract available


    August 2022
  3. WICKLAND DP, Sherman ME, Radisky DC, Mansfield AS, et al
    Lower Exome Sequencing Coverage of Ancestrally African Patients in The Cancer Genome Atlas.
    J Natl Cancer Inst. 2022;114:1192-1199.
    PubMed     Abstract available


    July 2022
  4. QING T, Mohsen H, Cannataro VL, Marczyk M, et al
    Cancer Relevance of Human Genes.
    J Natl Cancer Inst. 2022;114:988-995.
    PubMed     Abstract available


    February 2022
  5. TANAKA I, Dayde D, Tai MC, Mori H, et al
    SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.
    J Natl Cancer Inst. 2022;114:290-301.
    PubMed     Abstract available


  6. HEIN DM, Deng W, Bleile M, Kazmi SA, et al
    Racial and Ethnic Differences in Genomic Profiling of Early-Onset Colorectal Cancer.
    J Natl Cancer Inst. 2022 Feb 2. pii: 6520467. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  7. FOULKES WD, Polak P
    Li-Fraumeni Syndrome in the Cancer Genomics Era.
    J Natl Cancer Inst. 2021;113:1615-1617.
    PubMed    


  8. FOUNTZILAS E, Kurzrock R, Vo HH, Tsimberidou AM, et al
    Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a Matchmaker.
    J Natl Cancer Inst. 2021;113:1634-1647.
    PubMed     Abstract available


  9. EMENS LA
    Predictive Biomarkers: Progress on the Road to Personalized Cancer Immunotherapy.
    J Natl Cancer Inst. 2021;113:1601-1603.
    PubMed    


    October 2021
  10. BAKSHI A, Yan M, Riaz M, Polekhina G, et al
    Genomic Risk Score for Melanoma in a Prospective Study of Older Individuals.
    J Natl Cancer Inst. 2021;113:1379-1385.
    PubMed     Abstract available


    September 2021
  11. VARGHESE AM, Singh I, Singh R, Kunte S, et al
    Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes.
    J Natl Cancer Inst. 2021;113:1194-1202.
    PubMed     Abstract available


    July 2021
  12. SEMBA T, Wang X, Xie X, Cohen EN, et al
    Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated with an Immunosuppressive Tumor Microenvironment.
    J Natl Cancer Inst. 2021 Jul 12. pii: 6313157. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  13. WEST CML
    Identifying the Radioresponsive Genome for Genomics-Guided Radiotherapy.
    J Natl Cancer Inst. 2021;113:223-224.
    PubMed    


    May 2020
  14. YABROFF KR, Zhao J, de Moor JS, Sineshaw HM, et al
    Factors Associated With Oncologist Discussions of the Costs of Genomic Testing and Related Treatments.
    J Natl Cancer Inst. 2020;112:498-506.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Genetics is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: